Commonwealth Equity Services’s VanEck Pharmaceutical ETF PPH Stock Holding History

Commonwealth Equity Services’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.18M	Sell	10,821 -1,021	-9%	-$106K	﹤0.01%	2590
2026 Q1	$1.23M	Buy	11,842 +1,143	+11%	+$122K	﹤0.01%	2426
2025 Q4	$1.1M	Buy	10,699 +28	+0.3%	+$2.72K	﹤0.01%	2500
2025 Q3	$964K	Sell	10,671 -2,616	-20%	-$229K	﹤0.01%	2618
2025 Q2	$1.17M	Sell	13,287 -5,339	-29%	-$463K	﹤0.01%	2436
2025 Q1	$1.7M	Buy	18,626 +660	+4%	+$59.4K	﹤0.01%	2041
2024 Q4	$1.55M	Buy	17,966 +631	+4%	+$57.1K	﹤0.01%	2049
2024 Q3	$1.65M	Sell	17,335 -1,691	-9%	-$161K	﹤0.01%	1946
2024 Q2	$1.74M	Sell	19,026 -2,263	-11%	-$202K	﹤0.01%	1882
2024 Q1	$1.93M	Buy	21,289 +6,655	+45%	+$583K	﹤0.01%	1814
2023 Q4	$1.19M	Sell	14,634 -4,317	-23%	-$339K	﹤0.01%	2050
2023 Q3	$1.51M	Buy	18,951 +422	+2%	+$34K	﹤0.01%	1796
2023 Q2	$1.46M	Sell	18,529 -314	-2%	-$24.6K	﹤0.01%	1836
2023 Q1	$1.46M	Sell	18,843 -1,894	-9%	-$146K	﹤0.01%	1767
2022 Q4	$1.61M	Buy	20,737 +4,688	+29%	+$346K	﹤0.01%	1641
2022 Q3	$1.08M	Sell	16,049 -307	-2%	-$22.6K	﹤0.01%	1841
2022 Q2	$1.26M	Buy	16,356 +683	+4%	+$53.3K	﹤0.01%	1716
2022 Q1	$1.25M	Sell	15,673 -2,629	-14%	-$201K	﹤0.01%	1825
2021 Q4	$1.41M	Buy	18,302 +1,815	+11%	+$135K	﹤0.01%	1735
2021 Q3	$1.2M	Buy	16,487 +402	+2%	+$30K	﹤0.01%	1784
2021 Q2	$1.18M	Sell	16,085 -732	-4%	-$52.2K	﹤0.01%	1799
2021 Q1	$1.16M	Buy	16,817 +2,367	+16%	+$163K	﹤0.01%	1693
2020 Q4	$960K	Buy	14,450 +1,760	+14%	+$113K	﹤0.01%	1678
2020 Q3	$788K	Buy	12,690 +1,572	+14%	+$99.4K	﹤0.01%	1643
2020 Q2	$692K	Buy	+11,118	New	+$672K	﹤0.01%	1654

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

AWC

Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Commonwealth Equity Services's PPH Position: Q2 2026 in Review

Commonwealth Equity Services reduced its VanEck Pharmaceutical ETF (PPH) stake by 8.6% in Q2 2026, selling an estimated $106K and leaving 10,821 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2590.

Commonwealth Equity Services first reported a position in PPH in Q2 2020 and has held it in 25 quarters since. The position peaked at $1.93M in Q1 2024. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

Commonwealth Equity Services held 10,821 shares of VanEck Pharmaceutical ETF worth $1.18M as of Q2 2026.
Commonwealth Equity Services sold 1,021 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $106K.
VanEck Pharmaceutical ETF made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #2590 holding.
Commonwealth Equity Services first reported a position in VanEck Pharmaceutical ETF in Q2 2020 and has held it in 25 quarters since.
Commonwealth Equity Services's VanEck Pharmaceutical ETF position peaked at $1.93M in Q1 2024.
148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.